Corporate Responsibility And Public Benefit Report

Overview

The report describes United Therapeutics' 2022 performance, including $1.9 billion in product revenue, 985 employees, and continued progress in patient therapies and innovation. It reports 42% women on the board and a workforce in which 51% identify as women. The company established its GHG inventory approach in alignment with the GHG Protocol, although Scope 1 and Scope 2 emissions were not disclosed. ESG oversight was formalized through the Board's Nominating and Governance Committee, supported by an internal ESG Cabinet.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2022
Period: 1 January 2022 – 31 December 2022
Publication date: 12 September 2023
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services